Financial comparisons Illumina, Inc.
Equities
ILMN
US4523271090
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.21 USD | +0.53% | +4.90% | -6.49% |
09-13 | RBC Raises Price Target on Illumina to $252 From $242, Keeps Outperform Rating | MT |
09-06 | European Commission Withdraws Previous Decisions on Illumina-Grail Merger After Court Ruling | MT |
Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
---|---|---|---|---|---|---|---|
4.5B | -25.78% | +5.48% | +2.22% | +1.23% | 0.89x | ||
42.86B | +13.99% | +22.89% | +18.43% | +8.54% | 2.47x | ||
23.89B | +19.85% | +28.69% | +9.16% | +5.62% | 1.67x | ||
7.12B | +25.24% | +33.65% | +14.67% | +12.66% | -0.98x | ||
14.24B | +11.03% | +26.25% | +16.27% | +8.87% | 2.01x | ||
24.1B | +6.96% | +14.21% | +12.80% | +4.72% | 4.07x | ||
6B | +23.35% | +28.87% | +22.52% | +15.89% | -0.56x | ||
6.83B | +18.15% | +27.44% | +28.34% | +15.08% | 0.59x | ||
19.55B | +8.02% | +15.12% | +19.02% | - | 1.95x | ||
4.92B | +33.16% | +37.42% | +33.64% | +24.46% | -1.33x | ||
4.69B | +21.79% | +31.55% | +25.33% | +16.72% | 0.3x | ||
20.2B | -2.56% | +10.57% | +9.08% | +3.82% | 2.04x | ||
6.61B | +25.91% | +4.66% | +34.70% | +2.36% | -0.38x | ||
2.96B | +21.72% | +30.88% | +84.18% | +17.62% | 1.82x | ||
4.03B | +11.31% | +29.95% | +19.90% | +10.81% | 0.07x | ||
2.75B | +25.19% | +27.98% | +5.57% | +3.07% | 3.57x | ||
2.96B | +14.41% | +18.43% | +30.13% | +9.67% | 1.29x | ||
2.32B | +13.90% | +16.66% | +13.40% | +9.92% | -1.72x | ||
242M | -10.36% | -11.89% | -15.42% | -5.09% | -5.42x | ||
Average | 10.57B | +13.44% | +20.99% | +20.21% | +9.22% | 0.65x | |
Weighted average by Cap. | 19.38B | +16.41% | +25.44% | +17.64% | +9.54% | 1.25x |
- Stock Market
- Equities
- ILMN Stock
- Sector Illumina, Inc.
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition